Committees

TRANSFUSION SAFETY AND HAEMOVIGILANCE COMMITTEE – CSTH

The CSTH contributes to improving the quality and safety of blood transfusions for patients and implements haemovigilance and transfusion safety rules and procedures, in particular through the coordination of actions carried out in this field. The CSTH’s mission is to help improve the safety of patients receiving transfusions within the facility, in close collaboration with the French Blood Service (EFS).

MEDICINES AND STERILE MEDICAL DEVICES COMMITTEE – COMEDIMS

The COMEDIMS defines the policy for medicines, sterile medical devices and the management of medical fluids within the facility. It contributes to the development of the list of medicines and sterile medical devices recommended for use at Clinique de l’Alma, as well as to recommendations regarding prescribing practices, appropriate use of medicines and sterile medical devices, and the prevention of drug-related adverse events.

IDENTITOVIGILANCE UNIT – CIV

The CIV is responsible for organizing the prevention of errors related to patient identification. Identitovigilance encompasses all measures ensuring the correct identification of patients throughout the care pathway, particularly for patients who are unable to identify themselves.

PAIN MANAGEMENT COMMITTEE – CLUD

The Pain Management Committee (CLUD) is a forum for reflection and proposals on the prevention of pain caused by certain treatments or examinations (injections, dressings, catheter insertion, etc.), as well as pain sometimes associated with everyday actions such as personal hygiene or simple movement. The CLUD is also responsible for organizing the treatment and relief of acute post-operative pain, managed by the healthcare team through both scheduled and on-demand analgesic treatments, according to each patient’s level of pain.

If, during your hospital stay, you experience pain, you or a relative may inform the healthcare team and the physician in charge of your care. To help us better tailor your treatment, you can indicate how much pain you are experiencing by rating your pain on a scale from 0 to 10.

HEALTHCARE-ASSOCIATED INFECTIONS PREVENTION COMMITTEE (CLIAS – formerly CLIN)

The CLIAS is an official body whose primary role is to prevent healthcare-associated infections. It is based on the expertise of an Operational Hygiene Team (EOH). The CLIN works in close collaboration with the C-PIAS (Centre for the Prevention of Healthcare-Associated Infections): receiving guidance, issuing recommendations and alerts, disseminating targeted information to healthcare professionals within the facility, and reporting infectious incidents to national authorities as required by regulations.

MORBIDITY AND MORTALITY REVIEW – RMM AND FEEDBACK COMMITTEE – CREX

The RMM and CREX are responsible for carrying out a collective, retrospective, multidisciplinary and systemic analysis of cases involving death, complications, or events that could have caused harm to patients. The objective is to prevent the occurrence of serious adverse events through the structured management, analysis and follow-up of reported adverse events.

USER REPRESENTATIVES COMMITTEE – CDU

The User Representatives Committee was established under Article L.1112-3 of the French Public Health Code, Decree No. 2005-213 of 2 March 2005, and Decree No. 2016-726 of 1 June 2016. Its operation regarding the examination of complaints and claims submitted to it is governed by Articles R.1112-91 to 94 of the French Public Health Code.

Its missions:

• Ensure respect for users’ rights.
• Contribute to improving the reception of patients and their relatives.
• Contribute to improving the quality of care.
• Facilitate users’ procedures and ensure that they are able to express their complaints to the facility’s management, receive appropriate explanations, and be informed of the outcomes of their requests.

Its role within the facility:

• It is consulted on policies related to patient reception and care management and makes proposals in this area.
• It is informed of all complaints or claims submitted by users of the facility and of the actions taken in response.
• Right of access to medical data relating to complaints and claims, subject to obtaining the prior written consent of the person concerned or their legal representatives if deceased.
• Members of the committee are bound by professional confidentiality, medical confidentiality and respect for private life.

The regulations and list of CDU members are displayed within the Clinic and presented in the welcome booklet. You may contact the CDU by post at the Clinic’s address or by email by directly contacting the User Representatives at the following address:  usagers.turin@almaviva-sante.com.